Key points are not available for this paper at this time.
Metabolomics identified key disease-related metabolic changes and disease-progression-related changes. Defining metabolic changes during AD disease trajectory and its relationship to clinical phenotypes provides a powerful roadmap for drug and biomarker discovery.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jon B. Toledo
Houston Methodist
Matthias Arnold
Ingenieurgesellschaft Auto und Verkehr (Germany)
Gabi Kastenmüller
Queen Mary University of London
Alzheimer s & Dementia
National Institutes of Health
University of Pennsylvania
University of California, San Francisco
Building similarity graph...
Analyzing shared references across papers
Loading...
Toledo et al. (Tue,) studied this question.
synapsesocial.com/papers/69dd673c80eea7d3f699c834 — DOI: https://doi.org/10.1016/j.jalz.2017.01.020